(2016)
Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.
PLOS ONE 11(1),
e0147709.
Christine Skerka
AlumniPublications
(2016)
BGA66 and BGA71 facilitate complement resistance of Borrelia bavariensis by inhibiting assembly of the membrane attack complex.
Mol Immunol 99,
407-424.
(2016)
The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement.
Cell Microbiol 18(4),
573-590.
(2016)
Complement Regulator FHR-3 Is Elevated either Locally or Systemically in a Selection of Autoimmune Diseases.
Front Immunol 7,
542.
(2015)
Host-pathogen interactions between the human innate immune system and Candida albicans - Understanding and modeling defense and evasion strategies
Front Microbiol 6,
625.
(2015)
Activation of endogenously expressed ion channels by active complement in the retinal pigment epithelium.
Pflugers Arch 467(10),
2179-2191.
(2015)
Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.
PLOS One 10(9),
e0137630.
(2015)
Sequence variations and protein expression levels of the two immune evasion proteins Gpm1 and Pra1 influence virulence of clinical candida albicans isolates
PLOS One 10(2),
e0113192.
(2015)
Atypical aHUS: State of the art.
Mol Immunol 67(1),
31-42.
(2015)
Complement the alternative Pathway
Encyclopedia of Life Sciences; John Wiley & Sons, Ltd, Chichester
[In press]